Hyperinsulinemia has been widely proposed as a predisposing factor for stent restenosis in diabetic patients [39], and concerns have been raised over the management of diabetes with exogenously administered insulin, as it may accelerate progression of CAD through its atherogenic mechanisms [40,41]. This evidence concerns the gene INS and hyperinsulinism.